The Government has not received any recommendations from the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board to allow non-pharmacists to supervise the sale and supply of prescription medicines. In keeping with its terms of reference, the Rebalancing Programme Board is giving very careful consideration to the supervision of the sale and supply of medicines and the roles of registered pharmacists and registered pharmacy technicians, under the guidance of the four UK Chief Pharmaceutical Officers. Only when the Board has firm proposals will it make recommendations to Ministers and the devolved administrations. Any changes to legislation will be subject to full public consultation, including the completion of an impact assessment, underpinned by a quality systems approach, which maintains patient and public safety.<\/p>
<\/p>
The Rebalancing Programme Board meets regularly according to business need, having met three times in the last year. Full terms of reference and minutes of the meetings are published at:<\/p>
https://www.gov.uk/government/groups/pharmacy-regulation-programme-board<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "110278"}
, {"_value" : "110279"}
, {"_value" : "110280"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-02T12:24:05.45Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-30", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Prescription Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, whether it is his Department's policy that rules on pharmacy supervision should be changed to all non-pharmacists to supervise the sale and supply of prescription medicines; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4395", "label" : {"_value" : "Biography information for Baroness Hayman of Ullock"}
}
, "tablingMemberConstituency" : {"_value" : "Workington"}
, "tablingMemberPrinted" : [{"_value" : "Sue Hayman"}
], "uin" : "110277"}
, {"_about" : "http://data.parliament.uk/resources/780499", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/780499/answer", "answerText" : {"_value" : " Penalties are not imposed on National Health Service trusts in relation to car parking charges and actions.<\/p> <\/p> The NHS patient, visitor and staff car parking principles (first published in August 2014 and then updated in October 2015), set out a nationally consistent approach to determining car parking policies, making clear the rules which NHS trusts should follow when making decisions about car parking.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1542", "label" : {"_value" : "Biography information for Philip Dunne"}
}
, "answeringMemberConstituency" : {"_value" : "Ludlow"}
, "answeringMemberPrinted" : {"_value" : "Mr Philip Dunne"}
, "dateOfAnswer" : {"_value" : "2017-11-02", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-02T15:40:58.597Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-30", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hospitals: Parking"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what penalties are imposed on NHS hospitals which fail to follow his Department's guidance on charging staff, patients and visitors to park their vehicles in NHS car parks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/478", "label" : {"_value" : "Biography information for Lord Field of Birkenhead"}
}
, "tablingMemberConstituency" : {"_value" : "Birkenhead"}
, "tablingMemberPrinted" : [{"_value" : "Frank Field"}
], "uin" : "110284"}
, {"_about" : "http://data.parliament.uk/resources/780500", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/780500/answer", "answerText" : {"_value" : " The report of the Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests (including Primodos) is currently being finalised and is expected to be published before the end of the year.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-02", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-02T12:21:17.81Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-30", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Primodos"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what progress is being made on the inquiry into the Primodos hormone-based pregnancy test; and when he plans to publish the report.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/484", "label" : {"_value" : "Biography information for Dame Louise Ellman"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Riverside"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Louise Ellman"}
], "uin" : "110285"}
, {"_about" : "http://data.parliament.uk/resources/780502", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/780502/answer", "answerText" : {"_value" : " The Government has not received any recommendations from the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board to allow non-pharmacists to supervise the sale and supply of prescription medicines. In keeping with its terms of reference, the Rebalancing Programme Board is giving very careful consideration to the supervision of the sale and supply of medicines and the roles of registered pharmacists and registered pharmacy technicians, under the guidance of the four UK Chief Pharmaceutical Officers. Only when the Board has firm proposals will it make recommendations to Ministers and the devolved administrations. Any changes to legislation will be subject to full public consultation, including the completion of an impact assessment, underpinned by a quality systems approach, which maintains patient and public safety.<\/p> <\/p> The Rebalancing Programme Board meets regularly according to business need, having met three times in the last year. Full terms of reference and minutes of the meetings are published at:<\/p> https://www.gov.uk/government/groups/pharmacy-regulation-programme-board<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "110277"}
, {"_value" : "110279"}
, {"_value" : "110280"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-02T12:24:05.51Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-30", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how often the Pharmacy Rebalancing Board has met; and whether the minutes of those meetings are publicly available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4395", "label" : {"_value" : "Biography information for Baroness Hayman of Ullock"}
}
, "tablingMemberConstituency" : {"_value" : "Workington"}
, "tablingMemberPrinted" : [{"_value" : "Sue Hayman"}
], "uin" : "110278"}
, {"_about" : "http://data.parliament.uk/resources/780503", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/780503/answer", "answerText" : {"_value" : " The Government has not received any recommendations from the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board to allow non-pharmacists to supervise the sale and supply of prescription medicines. In keeping with its terms of reference, the Rebalancing Programme Board is giving very careful consideration to the supervision of the sale and supply of medicines and the roles of registered pharmacists and registered pharmacy technicians, under the guidance of the four UK Chief Pharmaceutical Officers. Only when the Board has firm proposals will it make recommendations to Ministers and the devolved administrations. Any changes to legislation will be subject to full public consultation, including the completion of an impact assessment, underpinned by a quality systems approach, which maintains patient and public safety.<\/p> <\/p> The Rebalancing Programme Board meets regularly according to business need, having met three times in the last year. Full terms of reference and minutes of the meetings are published at:<\/p>
Geography<\/p><\/td> | Calls triaged<\/p><\/td> | Ambulance dispatches<\/p><\/td> | Ambulance dispatches as a % of calls triaged<\/p><\/td><\/tr> |
England<\/p><\/td> | 12,090,555<\/p><\/td> | 1,548,989<\/p><\/td> | 12.8%<\/p><\/td><\/tr> |
North Region<\/p><\/td> | 3,554,832<\/p><\/td> | 481,828<\/p><\/td> | 13.6%<\/p><\/td><\/tr> |
Midlands and East Region<\/p><\/td> | 3,738,083<\/p><\/td> | 453,921<\/p><\/td> | 12.1%<\/p><\/td><\/tr> |
London Region<\/p><\/td> | 1,449,855<\/p><\/td> | 164,137<\/p><\/td> | 11.3%<\/p><\/td><\/tr> |
South Region<\/p><\/td> | 3,347,785<\/p><\/td> | 449,103<\/p><\/td> | 13.4%<\/p><\/td><\/tr> |
North East<\/p><\/td> | 730,804<\/p><\/td> | 122,068<\/p><\/td> | 16.7%<\/p><\/td><\/tr> |
North West including Blackpool<\/p><\/td> | 1,411,961<\/p><\/td> | 205,502<\/p><\/td> | 14.6%<\/p><\/td><\/tr> |
Yorkshire and Humber<\/p><\/td> | 1,412,067<\/p><\/td> | 154,258<\/p><\/td> | 10.9%<\/p><\/td><\/tr> |
Lincolnshire<\/p><\/td> | 173,197<\/p><\/td> | 22,240<\/p><\/td> | 12.8%<\/p><\/td><\/tr> |
Nottinghamshire<\/p><\/td> | 247,442<\/p><\/td> | 31,175<\/p><\/td> | 12.6%<\/p><\/td><\/tr> |
Derbyshire<\/p><\/td> | 269,553<\/p><\/td> | 31,539<\/p><\/td> | 11.7%<\/p><\/td><\/tr> |
Leicestershire and Rutland<\/p><\/td> | 221,052<\/p><\/td> | 28,968<\/p><\/td> | 13.1%<\/p><\/td><\/tr> |
Northamptonshire<\/p><\/td> | 181,749<\/p><\/td> | 21,619<\/p><\/td> | 11.9%<\/p><\/td><\/tr> |
Milton Keynes<\/p><\/td> | 54,419<\/p><\/td> | 6,285<\/p><\/td> | 11.5%<\/p><\/td><\/tr> |
Staffordshire<\/p><\/td> | 232,181<\/p><\/td> | 29,504<\/p><\/td> | 12.7%<\/p><\/td><\/tr> |
West Midlands excluding Staffordshire<\/p><\/td> | 865,480<\/p><\/td> | 113,881<\/p><\/td> | 13.2%<\/p><\/td><\/tr> |
Norfolk including Great Yarmouth and Waveney<\/p><\/td> | 274,902<\/p><\/td> | 38,294<\/p><\/td> | 13.9%<\/p><\/td><\/tr> |
Suffolk<\/p><\/td> | 162,263<\/p><\/td> | 20,933<\/p><\/td> | 12.9%<\/p><\/td><\/tr> |
Cambridgeshire and Peterborough<\/p><\/td> | 193,331<\/p><\/td> | 23,488<\/p><\/td> | 12.1%<\/p><\/td><\/tr> |
Luton and Bedfordshire<\/p><\/td> | 111,665<\/p><\/td> | 13,926<\/p><\/td> | 12.5%<\/p><\/td><\/tr> |
Hertfordshire<\/p><\/td> | 264,432<\/p><\/td> | 25,939<\/p><\/td> | 9.8%<\/p><\/td><\/tr> |
North Essex<\/p><\/td> | 254,613<\/p><\/td> | 24,946<\/p><\/td> | 9.8%<\/p><\/td><\/tr> |
South Essex<\/p><\/td> | 231,804<\/p><\/td> | 21,184<\/p><\/td> | 9.1%<\/p><\/td><\/tr> |
Outer North East London<\/p><\/td> | 225,371<\/p><\/td> | 25,508<\/p><\/td> | 11.3%<\/p><\/td><\/tr> |
East London and City<\/p><\/td> | 101,269<\/p><\/td> | 10,949<\/p><\/td> | 10.8%<\/p><\/td><\/tr> |
North Central London<\/p><\/td> | 268,822<\/p><\/td> | 29,061<\/p><\/td> | 10.8%<\/p><\/td><\/tr> |
Inner North West London<\/p><\/td> | 111,426<\/p><\/td> | 12,184<\/p><\/td> | 10.9%<\/p><\/td><\/tr> |
Outer North West London<\/p><\/td> | 170,177<\/p><\/td> | 22,433<\/p><\/td> | 13.2%<\/p><\/td><\/tr> |
Hillingdon<\/p><\/td> | 61,178<\/p><\/td> | 7,998<\/p><\/td> | 13.1%<\/p><\/td><\/tr> |
South West London<\/p><\/td> | 252,100<\/p><\/td> | 30,592<\/p><\/td> | 12.1%<\/p><\/td><\/tr> |
South East London<\/p><\/td> | 259,512<\/p><\/td> | 25,412<\/p><\/td> | 9.8%<\/p><\/td><\/tr> |
Isle of Wight<\/p><\/td> | 72,006<\/p><\/td> | 9,355<\/p><\/td> | 13.0%<\/p><\/td><\/tr> |
Mainland SHIP<\/p><\/td> | 479,440<\/p><\/td> | 56,839<\/p><\/td> | 11.9%<\/p><\/td><\/tr> |
Berkshire<\/p><\/td> | 218,423<\/p><\/td> | 24,503<\/p><\/td> | 11.2%<\/p><\/td><\/tr> |
Buckinghamshire<\/p><\/td> | 122,657<\/p><\/td> | 12,582<\/p><\/td> | 10.3%<\/p><\/td><\/tr> |
Oxfordshire<\/p><\/td> | 172,932<\/p><\/td> | 18,437<\/p><\/td> | 10.7%<\/p><\/td><\/tr> |
Gloucestershire and Swindon<\/p><\/td> | 138,768<\/p><\/td> | 18,827<\/p><\/td> | 13.6%<\/p><\/td><\/tr> |
Bath and North East Somerset and Wiltshire<\/p><\/td> | 133,284<\/p><\/td> | 17,853<\/p><\/td> | 13.4%<\/p><\/td><\/tr> |
Bristol, North Somerset and South Gloucestershire<\/p><\/td> | 280,221<\/p><\/td> | 36,139<\/p><\/td> | 12.9%<\/p><\/td><\/tr> |
Somerset<\/p><\/td> | 116,358<\/p><\/td> | 16,665<\/p><\/td> | 14.3%<\/p><\/td><\/tr> |
Dorset<\/p><\/td> | 194,280<\/p><\/td> | 29,935<\/p><\/td> | 15.4%<\/p><\/td><\/tr> |
Devon<\/p><\/td> | 276,988<\/p><\/td> | 47,541<\/p><\/td> | 17.2%<\/p><\/td><\/tr> |
Cornwall<\/p><\/td> | 132,879<\/p><\/td> | 23,043<\/p><\/td> | 17.3%<\/p><\/td><\/tr> |
South East Coast<\/p><\/td> | 1,009,549<\/p><\/td> | 37,384<\/p><\/td> | 13.6%<\/p><\/td><\/tr><\/tbody><\/table> |